title: Belimumab in primary antiphospholipid syndrome.
authors.affiliation: 1 Kocaeli University School of Medicine, Turkey.
authors.forename: A
authors.initials: A
authors.lastname: Yazici
authors.affiliation: 2 Cerrahpasa School of Medicine, Istanbul University, Turkey.
authors.forename: B
authors.initials: B
authors.lastname: Yazirli
authors.affiliation: 3 Hospital for Special Surgery, Weill Cornell Medicine, New York, USA.
authors.forename: D
authors.initials: D
authors.lastname: Erkan
mesh_terms: D000328:Adult; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage*; D016736:Antiphospholipid Syndrome / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D012008:Recurrence; D012883:Skin Ulcer / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D061067:Antibodies, Monoclonal, Humanized; C511911:belimumab
keywords: Antiphospholipid syndrome; B cell therapy; belimumab